The current management of gastrointestinal stromal tumors.
Efron
David T
DT
The Johns Hopkins Medical Institution, Baltimore, Maryland, USA.
Lillemoe
Keith D
KD
D001549:Benzamides; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000601:surgery; D003663:Decision Trees; D004938:Esophageal Neoplasms / Q000601:surgery; D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism / Q000601:surgery*; D006801:Humans; D000068877:Imatinib Mesylate; D007150:Immunohistochemistry; D007414:Intestinal Neoplasms / Q000601:surgery; D008279:Magnetic Resonance Imaging; D010879:Piperazines / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D019009:Proto-Oncogene Proteins c-kit / Q000378:metabolism; D011743:Pyrimidines / Q000627:therapeutic use; D012004:Rectal Neoplasms / Q000601:surgery; D018570:Risk Assessment; D013274:Stomach Neoplasms / Q000601:surgery; D014057:Tomography, X-Ray Computed
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases; D019009:Proto-Oncogene Proteins c-kit